Share Price and Basic Stock Data

Last Updated: November 22, 2024, 9:04 pm

Market Cap	124 Cr.
Current Price	200
High / Low	307/112
Stock P/E	20.2
Book Value	69.6
Dividend Yield	0.00 %
ROCE	20.4 %
ROE	20.5 %
Face Value	10.0
PEG Ratio	12.78

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Auro Laboratories Ltd

Competitors of Auro Laboratories Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Gujarat Themis Biosyn Ltd	3,399 Cr.	312	390/108	64.5	20.5	0.21 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	58.6 Cr.	79.0	94.9/25.8	22.5	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	28.0 Cr.	19.1	19.5/8.35	36.3	6.64	0.00 %	4.06 %	3.33 %	10.0
Godavari Drugs Ltd	86.2 Cr.	114	155/87.0	12.9	55.4	0.00 %	12.7 %	15.5 %	10.0
Glenmark Life Sciences Ltd	12,813 Cr.	1,046	1,335/625	30.2	207	2.15 %	28.1 %	21.1 %	2.00
Industry Average	19,448.38 Cr	1,190.01		55.11	184.88	0.32%	16.40%	16.92%	6.61

All Competitor Stocks of Auro Laboratories Ltd

Quarterly Result

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	10.53	10.32	12.14	17.88	11.19	12.56	15.62	13.52	10.18	13.41	17.98	12.06	5.72
Expenses	9.16	9.20	10.93	16.97	10.62	11.54	15.17	11.17	9.02	10.38	13.90	9.65	4.39
Operating Profit	1.37	1.12	1.21	0.91	0.57	1.02	0.45	2.35	1.16	3.03	4.08	2.41	1.33
OPM %	13.01%	10.85%	9.97%	5.09%	5.09%	8.12%	2.88%	17.38%	11.39%	22.60%	22.69%	19.98%	23.25%
Other Income	0.50	0.29	0.02	0.28	0.05	-0.16	0.43	0.62	0.36	0.32	0.42	0.40	0.20
Interest	0.11	0.15	0.16	0.40	0.26	0.32	0.10	0.13	0.27	0.35	0.44	-0.32	0.25
Depreciation	0.26	0.26	0.26	0.24	0.25	0.25	0.27	0.30	0.27	0.27	0.27	0.28	0.27
Profit before tax	1.50	1.00	0.81	0.55	0.11	0.29	0.51	2.54	0.98	2.73	3.79	2.85	1.01
Tax %	29.33%	29.00%	24.69%	16.36%	27.27%	27.59%	27.45%	29.53%	27.55%	27.84%	27.70%	18.60%	24.75%
Net Profit	1.07	0.71	0.61	0.46	0.08	0.21	0.37	1.78	0.71	1.97	2.73	2.32	0.75
EPS in Rs	1.72	1.14	0.98	0.74	0.13	0.34	0.59	2.86	1.14	3.16	4.38	3.72	1.20

Last Updated: October 7, 2024, 8:35 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	44.28	33.74	32.65	27.91	35.47	40.79	46.82	43.79	54.25	50.87	52.89	53.64	49.17
Expenses	41.01	30.95	29.71	25.11	31.03	34.43	39.83	37.51	43.01	46.24	48.50	42.96	38.32
Operating Profit	3.27	2.79	2.94	2.80	4.44	6.36	6.99	6.28	11.24	4.63	4.39	10.68	10.85
OPM %	7.38%	8.27%	9.00%	10.03%	12.52%	15.59%	14.93%	14.34%	20.72%	9.10%	8.30%	19.91%	22.07%
Other Income	0.06	0.06	0.24	0.42	0.53	0.51	0.96	0.97	0.76	1.09	0.94	1.50	1.34
Interest	1.85	1.53	1.66	1.66	1.18	1.21	0.87	0.58	0.46	0.83	0.81	0.74	0.72
Depreciation	0.72	0.74	0.72	0.68	0.86	0.93	1.01	1.02	1.04	1.02	1.07	1.09	1.09
Profit before tax	0.76	0.58	0.80	0.88	2.93	4.73	6.07	5.65	10.50	3.87	3.45	10.35	10.38
Tax %	0.00%	0.00%	0.00%	0.00%	72.01%	25.16%	27.51%	27.96%	31.62%	26.61%	28.99%	24.64%
Net Profit	0.77	0.58	0.80	0.88	0.82	3.53	4.40	4.05	7.18	2.84	2.44	7.79	7.77
EPS in Rs	1.24	0.93	1.28	1.41	1.32	5.66	7.06	6.50	11.52	4.56	3.91	12.50	12.46
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-24.68%	37.93%	10.00%	-6.82%	330.49%	24.65%	-7.95%	77.28%	-60.45%	-14.08%	219.26%
Change in YoY Net Profit Growth (%)	0.00%	62.61%	-27.93%	-16.82%	337.31%	-305.84%	-32.60%	85.24%	-137.73%	46.36%	233.35%

Auro Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	3%
3 Years:	0%
TTM:	-26%

Compounded Profit Growth
10 Years:	30%
5 Years:	12%
3 Years:	3%
TTM:	28%

Stock Price CAGR
10 Years:	38%
5 Years:	30%
3 Years:	25%
1 Year:	44%

Return on Equity
10 Years:	18%
5 Years:	17%
3 Years:	13%
Last Year:	20%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 5:47 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23	6.23
Reserves	0.09	0.67	1.47	2.35	3.18	6.75	11.18	15.27	22.35	25.29	27.97	35.73	37.13
Borrowings	16.75	14.80	16.41	12.62	4.95	9.20	8.09	3.16	3.16	13.78	6.41	26.25	34.22
Other Liabilities	6.75	5.14	4.67	4.49	12.45	8.23	7.97	7.68	10.15	9.66	15.38	17.52	6.45
Total Liabilities	29.82	26.84	28.78	25.69	26.81	30.41	33.47	32.34	41.89	54.96	55.99	85.73	84.03
Fixed Assets	10.68	10.51	9.80	9.13	13.00	13.02	14.59	14.24	13.56	13.61	12.62	22.15	21.61
CWIP	0.00	0.06	0.82	3.33	0.23	1.07	0.12	0.12	0.13	3.68	7.67	32.68	39.86
Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Other Assets	19.09	16.22	18.11	13.18	13.53	16.27	18.71	17.93	28.15	37.62	35.65	30.85	22.51
Total Assets	29.82	26.84	28.78	25.69	26.81	30.41	33.47	32.34	41.89	54.96	55.99	85.73	84.03

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	1.46	4.48	-0.78	7.88	6.49	6.05	6.87	9.30	12.82	-6.59	3.28	18.81
Cash from Investing Activity +	-0.52	-0.56	-0.73	-2.44	-2.20	-3.04	-3.19	-2.21	-3.51	-5.34	-5.08	-38.67
Cash from Financing Activity +	-0.79	-2.99	0.53	-5.34	-3.81	-1.77	-1.83	-5.52	-0.46	9.79	-8.18	19.09
Net Cash Flow	0.15	0.93	-0.98	0.09	0.47	1.24	1.86	1.58	8.85	-2.14	-9.98	-0.77

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-13.48	-12.01	-13.47	-9.82	-0.51	-2.84	-1.10	3.12	8.08	-9.15	-2.02	-15.57

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	66.52	46.95	94.80	66.04	79.13	74.90	66.26	48.18	49.12	97.65	85.57	91.11
Inventory Days	72.37	115.33	89.37	86.72	21.65	22.00	42.98	60.54	32.60	47.32	120.27	113.24
Days Payable	64.73	62.97	56.12	72.03	80.26	78.26	66.19	70.67	73.51	54.12	117.41	85.34
Cash Conversion Cycle	74.17	99.30	128.05	80.73	20.52	18.64	43.05	38.04	8.20	90.86	88.44	119.01
Working Capital Days	89.27	94.12	138.51	97.17	67.20	64.70	63.46	51.09	33.84	123.56	134.64	89.41
ROCE %	11.71%	9.43%	10.74%	11.21%	23.06%	32.51%	29.11%	24.84%	38.87%	12.20%	9.92%	20.38%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Promoters	51.92%	51.92%	51.93%	51.99%	51.99%	52.09%	52.09%	52.09%	52.09%	52.09%	52.09%	52.09%
DIIs	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	48.07%	48.07%	48.06%	48.00%	48.00%	47.91%	47.91%	47.92%	47.90%	47.90%	47.92%	47.90%
No. of Shareholders	9,151	9,377	10,129	10,189	11,340	11,362	11,183	11,135	10,906	10,501	10,272	9,905

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	12.50	3.92	4.56	11.52	6.51
Diluted EPS (Rs.)	12.50	3.92	4.56	11.52	6.51
Cash EPS (Rs.)	14.26	5.64	6.20	13.18	8.15
Book Value[Excl.RevalReserv]/Share (Rs.)	67.32	54.87	50.58	45.86	34.49
Book Value[Incl.RevalReserv]/Share (Rs.)	67.32	54.87	50.58	45.86	34.49
Revenue From Operations / Share (Rs.)	86.06	84.87	81.61	87.05	70.26
PBDIT / Share (Rs.)	19.53	8.56	9.17	19.25	11.44
PBIT / Share (Rs.)	17.78	6.83	7.54	17.59	9.80
PBT / Share (Rs.)	16.60	5.53	6.21	16.86	9.05
Net Profit / Share (Rs.)	12.50	3.92	4.56	11.52	6.50
PBDIT Margin (%)	22.69	10.08	11.24	22.11	16.28
PBIT Margin (%)	20.66	8.05	9.24	20.20	13.94
PBT Margin (%)	19.28	6.51	7.61	19.36	12.88
Net Profit Margin (%)	14.52	4.61	5.59	13.23	9.25
Return on Networth / Equity (%)	18.57	7.14	9.02	25.11	18.86
Return on Capital Employeed (%)	17.93	11.25	13.49	32.80	23.30
Return On Assets (%)	9.08	4.36	5.17	17.13	12.53
Long Term Debt / Equity (X)	0.43	0.05	0.02	0.07	0.08
Total Debt / Equity (X)	0.62	0.18	0.02	0.07	0.08
Asset Turnover Ratio (%)	0.75	0.95	1.05	1.46	1.33
Current Ratio (X)	1.29	1.97	1.87	3.32	2.93
Quick Ratio (X)	0.94	1.32	1.66	3.02	2.26
Inventory Turnover Ratio (X)	2.90	4.66	9.92	8.30	6.30
Interest Coverage Ratio (X)	16.55	6.55	6.92	26.18	15.29
Interest Coverage Ratio (Post Tax) (X)	11.59	4.00	4.44	16.66	9.69
Enterprise Value (Cr.)	125.03	37.80	50.97	38.05	15.73
EV / Net Operating Revenue (X)	2.33	0.71	1.00	0.70	0.35
EV / EBITDA (X)	10.27	7.09	8.91	3.17	2.21
MarketCap / Net Operating Revenue (X)	1.87	0.64	1.23	0.93	0.44
Price / BV (X)	2.39	0.99	1.98	1.77	0.91
Price / Net Operating Revenue (X)	1.87	0.64	1.23	0.93	0.44
EarningsYield	0.07	0.07	0.04	0.14	0.20

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Auro Laboratories Ltd as of November 25, 2024 is: 293.98

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 25, 2024, Auro Laboratories Ltd is Undervalued by 46.99% compared to the current share price 200.00

Intrinsic Value of Auro Laboratories Ltd as of November 25, 2024 is: 298.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 25, 2024, Auro Laboratories Ltd is Undervalued by 49.32% compared to the current share price 200.00

Last 5 Year EPS CAGR: 1.58%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.50%, which is a positive sign. The company has higher reserves (14.57 cr) compared to borrowings (13.06 cr), indicating strong financial stability. The company has shown consistent growth in sales (43.56 cr) and profit (4.69 cr) over the years.	The stock has a high average Working Capital Days of 87.25, which may not be favorable. The stock has a high average Cash Conversion Cycle of 67.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Auro Laboratories Ltd:
1. Net Profit Margin: 14.52%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 17.93% (Industry Average ROCE: 16.4%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 18.57% (Industry Average ROE: 16.92%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 11.59
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.94
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 20.2 (Industry average Stock P/E: 55.11)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.62
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Auro Laboratories Ltd. is a Public Limited Listed company incorporated on 26/05/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L33125MH1989PLC051910 and registration number is 051910. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 50.87 Cr. and Equity Capital is Rs. 6.23 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	K-56, M.I.D.C. Industrial Area, Tarapur, Boisar, Palghar District Maharashtra 401506	auro@aurolabs.com http://www.aurolabs.com

Management
Name	Position Held
Mr. Sharat Deorah	Chairman & Managing Director
Mr. Siddhartha Deorah	Whole Time Director
Mr. Kiran Suresh Kulkarni	Whole Time Director
Mrs. Kavita Vijayakant Sharma	Ind. Non-Executive Director
Mr. Vishal Kailashchandra Jhunjhunwala	Ind. Non-Executive Director
Mr. Mahendra Kumar Daga	Ind. Non-Executive Director

FAQ

What is the latest intrinsic value of Auro Laboratories Ltd?

The latest intrinsic value of Auro Laboratories Ltd as on 24 November 2024 is ₹293.98, which is 46.99% higher than the current market price of ₹200.00.

What is the Market Cap of Auro Laboratories Ltd?

The Market Cap of Auro Laboratories Ltd is 124 Cr..

What is the current Stock Price of Auro Laboratories Ltd as on 24 November 2024?

The current stock price of Auro Laboratories Ltd as on 24 November 2024 is 200.

What is the High / Low of Auro Laboratories Ltd stocks in FY 2024?

In FY 2024, the High / Low of Auro Laboratories Ltd stocks is 307/112.

What is the Stock P/E of Auro Laboratories Ltd?

The Stock P/E of Auro Laboratories Ltd is 20.2.

What is the Book Value of Auro Laboratories Ltd?

The Book Value of Auro Laboratories Ltd is 69.6.

What is the Dividend Yield of Auro Laboratories Ltd?

The Dividend Yield of Auro Laboratories Ltd is 0.00 %.

What is the ROCE of Auro Laboratories Ltd?

The ROCE of Auro Laboratories Ltd is 20.4 %.

What is the ROE of Auro Laboratories Ltd?

The ROE of Auro Laboratories Ltd is 20.5 %.

What is the Face Value of Auro Laboratories Ltd?

The Face Value of Auro Laboratories Ltd is 10.0.